Efficacy and Safety of Atorvastatin in Combination With Radiotherapy and Temozolomide in Glioblastoma
Status:
Completed
Trial end date:
2016-12-31
Target enrollment:
Participant gender:
Summary
The purpose of this study is to explore the efficacy and safety of Atorvastatin in
combination with multimodality therapy of concurrent radiotherapy plus temozolomide followed
by adjuvant temozolomide in patients with newly diagnosed glioblastoma multiforme (GBM).The
anticipated time on study treatment is until disease progression, and the target sample size
is 32 individuals.